Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report

• Barbara Castelli,
• Barbara Castelli,
• Carla Fonte,
• Milena Guidi,
• Milena Guidi,
• Marco Tellini,
• Marco Di Nicola,
• Alessandro Iacono,
• Anna Maria Buccoliero,
• Daniela Greto,
• Lorenzo Genitori,
• Iacopo Sardi

Affiliations

Barbara Castelli

Health Sciences Department, University of Florence, Florence, Italy

Barbara Castelli

Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Carla Fonte

Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Milena Guidi

Health Sciences Department, University of Florence, Florence, Italy

Milena Guidi

Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Marco Tellini

Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Marco Di Nicola

Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Alessandro Iacono

Radiology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Anna Maria Buccoliero

Pathology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Daniela Greto

Radiotherapy Unit, University of Florence, Florence, Italy

Lorenzo Genitori

Neurosurgery Unit, Meyer Children’s Hospital IRCCS, Florence, Italy

Iacopo Sardi

Neuro-Oncology Unit, Meyer Children’s Hospital IRCCS, Florence, Italy